The cost-effectiveness of dapagliflozin in treating high risk patients with type 2 diabetes mellitus: an economic evaluation using data from the DECLARE-TIMI 58 trial
| Image |  |
|---|---|
| Description | scientific article published on 28 December 2020 |
| Author/s |
author: John Wilding Avivit Cahn Phil McEwan Angharad Morgan Ofri Mosenzon Lawrence A Leiter |
| Publication date | December 28, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |